3-D bioprinter capable of generating a 3D construct with pluripotent stem cells and their differentiated counterparts

COMBINED SYNOPSIS / SOLICITATION
COMPETITIVE

Title: 3-D bioprinter capable of generating a 3D construct with pluripotent stem cells and their differentiated counterparts

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95019Q00150 and the solicitation is issued as a request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-01 dated January 22, 2019.

(iv) The associated NAICS code is 333244 and the small business size standard is 750 employees. This requirement is set aside for small businesses.

(v) Line numbers, items, and quantities: Line 1: 3-D bioprinter, two each.

(vi) This acquisition is for two bioprinters capable of generating a 3D construct with pluripotent stem cells and their differentiated counterparts. The salient characteristics of the 3-D bioprinters include:

- The ability to generate a 3D construct with pluripotent stem cells and their differentiated counterparts, to include (but not limited to) mesenchymal stem cells, chondrocytes, cardiac progenitor cells, human umbilical vein endothelial cells, neural stem cells, and pluripotent stem cells;
- Layer and positioning resolution up to 1 µm;
- Clean chamber environmental features to include:
o HEPA filter
o UV-C germicidal lamp
- Exchangeable termperature-controllable printheads;
- Printheads and printhead modes that include at least pneumatic, inkjet, syringe pump, and thermoplastic filament extrusion options;
- HD camera tool head included;
- Photocuring tool head to support at least both 365 nm and 405 nm UV light sources included;
- Ability to use a wide variety of biocompatible bio-inks, as well as the availability of those inks. Bio-ink availability should include: polysaccharide hydrogel for universal printing of various cell lines, RGD peptides-integrated bioink for improved cell attachment, sodium alginate-based bioink for biodegradable support, thermoplastic bio-ink for development of load-bearing tissue constructs, and bio-conductive ink to support generation of electrically active tissue, such as nerve and heart tissue;
- Installation;
- Training.

(vii) Delivery shall be to the National Center for Advancing Translational Sciences (NCATS), NIH, 9800 Medical Center Drive, Rockville, MD 20850, and is to be within 4 weeks after receipt of order. Offeror is to propose FOB terms. Shipping costs must be included in the quote.

(viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition.

(ix) Offers will be evaluated for technical criteria, price, and past performance using a comparative approach. A contract will be awarded to the offer that is determined to be most advantageous to the Government. Technical criteria consist of addressing the salient criteria identified above. Technical and past performance, when combined, are significantly more important than price.

(x) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer.

(xi) The FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. An addendum applies to this acquisition and is included with this solicitation.

(xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition, and is included with this solicitation.

(xiii) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by Monday, May 13, 2019, at 11:00 a.m. Eastern time, and reference number 75N95019Q00150. Responses must be submitted electronically to Stuart Kern, Contract Specialist, stuart.kern@nih.gov, 301-402-3334.

Fax responses will not be accepted.

.